Velphoro® (sucroferric oxyhydroxide) chewable tablet 500 mg iron. Velphoro is indicated for the control of serum phosphorus levels in adult patients with end-stage renal disease (ESRD) on haemodialysis or peritoneal dialysis. Kindly consult your healthcare professionals for further advice. 


Velphoro® chewable tablet. Red-brown, round, flat-faced tablets embossed with PA500 on one side.
Each tablet of Velphoro contains 500 mg iron as sucroferric oxyhydroxide also known as a mixture of polynuclear iron (III)-oxyhydroxide, sucrose and starches.

  • Sucroferric oxyhydroxide (mixture of polynuclear iron (III)-oxyhydroxide, sucrose, starches) 2,500.00 mg (Active Ingredient)
  • Woodberry flavour 40.00 mg (Flavour)
  • Neohesperidin dihydrochalcone 0.01 mg (Sweetener) 
  • Magnesium stearate 25.00 mg (Lubricant) 
  • Silica (colloidal, anhydrous) 12.49 mg (Flow aid)

Product Information

Please note that this product may not be available in all countries due to different registration status. Additionally, approved indications, contraindications, side effects, warnings and all other product characteristics may differ between countries.

If you require any information, please contact your local organization.